Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16370 | TPP | 1/1 | Bang Zheng | 3 years, 3 months ago 15 March 2023 17:20:22 UTC | View, Job request 16370 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16368 | TPP | 2/2 | Linda Nab | 3 years, 3 months ago 15 March 2023 17:07:45 UTC | View, Job request 16368 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16367 | TPP | 36/36 | Linda Nab | 3 years, 3 months ago 15 March 2023 16:58:10 UTC | View, Job request 16367 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16365 | TPP | 2/2 | Linda Nab | 3 years, 3 months ago 15 March 2023 16:50:09 UTC | View, Job request 16365 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16364 | TPP | 10/12 | Linda Nab | 3 years, 3 months ago 15 March 2023 16:42:38 UTC | View, Job request 16364 |
| Succeeded | GP appointments during COVID | winter-pressures | 16363 | TPP | 6/6 | Lisa Hopcroft | 3 years, 3 months ago 15 March 2023 16:40:41 UTC | View, Job request 16363 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16355 | TPP | 4/4 | Linda Nab | 3 years, 3 months ago 15 March 2023 14:59:57 UTC | View, Job request 16355 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16352 | TPP | 4/4 | Linda Nab | 3 years, 3 months ago 15 March 2023 14:02:52 UTC | View, Job request 16352 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16350 | TPP | 20/20 | Linda Nab | 3 years, 3 months ago 15 March 2023 13:42:24 UTC | View, Job request 16350 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16349 | TPP | 2/6 | Linda Nab | 3 years, 3 months ago 15 March 2023 13:39:23 UTC | View, Job request 16349 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16348 | TPP | 0/20 | Linda Nab | 3 years, 3 months ago 15 March 2023 13:38:12 UTC | View, Job request 16348 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16344 | TPP | 20/20 | Linda Nab | 3 years, 3 months ago 15 March 2023 13:09:12 UTC | View, Job request 16344 |
| Succeeded | Scarlet fever and invasive group A strep cases during the COVID-19 pandemic | strepa_scarlet | 16341 | TPP | 2/2 | Christine Cunningham | 3 years, 3 months ago 15 March 2023 12:52:42 UTC | View, Job request 16341 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16339 | TPP | 0/20 | Linda Nab | 3 years, 3 months ago 15 March 2023 12:36:18 UTC | View, Job request 16339 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16317 | TPP | 44/44 | Linda Nab | 3 years, 3 months ago 14 March 2023 17:05:43 UTC | View, Job request 16317 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16316 | TPP | 2/2 | Linda Nab | 3 years, 3 months ago 14 March 2023 16:53:39 UTC | View, Job request 16316 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16314 | TPP | 2/2 | Linda Nab | 3 years, 3 months ago 14 March 2023 16:39:02 UTC | View, Job request 16314 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16305 | TPP | 12/12 | Linda Nab | 3 years, 3 months ago 14 March 2023 15:16:49 UTC | View, Job request 16305 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16301 | TPP | 0/12 | Linda Nab | 3 years, 3 months ago 14 March 2023 15:09:31 UTC | View, Job request 16301 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16297 | TPP | 6/6 | Linda Nab | 3 years, 3 months ago 14 March 2023 14:12:49 UTC | View, Job request 16297 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16293 | TPP | 20/20 | Linda Nab | 3 years, 3 months ago 14 March 2023 13:18:21 UTC | View, Job request 16293 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16291 | TPP | 20/20 | Linda Nab | 3 years, 3 months ago 14 March 2023 13:15:30 UTC | View, Job request 16291 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16289 | TPP | 5/5 | Bang Zheng | 3 years, 3 months ago 14 March 2023 12:38:57 UTC | View, Job request 16289 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16277 | TPP | 1/1 | Bang Zheng | 3 years, 3 months ago 14 March 2023 08:54:11 UTC | View, Job request 16277 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16276 | TPP | 1/1 | Bang Zheng | 3 years, 3 months ago 13 March 2023 23:39:06 UTC | View, Job request 16276 |